Janna Jernigan Posey, PhD, is a project manager for Team Liddle as a part of Aligning Science Across Parkinson’s (ASAP). She is also a Postdoctoral Research Fellow and T32 Training Grant Appointee as a part of the ADRD at the Stark Neuroscience Research Institute. Dr. Jernigan Posey’s research focuses on investigating chronic systemic inflammation and the central-peripheral inflammatory axis in the onset and progression of neurodegenerative diseases. Dr. Jernigan Posey received her BS in Biology and Psychology from the University of Georgia and then completed her PhD at the University of Florida. Across these institutions, her research centered on understanding how metabolic and chronic inflammatory stressors impact central and peripheral immune responses pertinent to the development of downstream neuropathology. Moreover, Dr. Jernigan Posey’s work examined how changes in relevant immunoregulatory proteins, such as RGS10, influenced the development of potential disease-relevant immunophenotypes.
Project Manager
Janna Jernigan Posey, PhD
Indiana University
Janna Jernigan Posey, PhD, is a project manager for Team Liddle as a part of Aligning Science Across Parkinson’s (ASAP). She is also a Postdoctoral Research Fellow and T32 Training Grant Appointee as a part of the ADRD at the Stark Neuroscience Research Institute. Dr. Jernigan Posey’s research focuses on investigating chronic systemic inflammation and the central-peripheral inflammatory axis in the onset and progression of neurodegenerative diseases. Dr. Jernigan Posey received her BS in Biology and Psychology from the University of Georgia and then completed her PhD at the University of Florida. Across these institutions, her research centered on understanding how metabolic and chronic inflammatory stressors impact central and peripheral immune responses pertinent to the development of downstream neuropathology. Moreover, Dr. Jernigan Posey’s work examined how changes in relevant immunoregulatory proteins, such as RGS10, influenced the development of potential disease-relevant immunophenotypes.
